Oral and parenteral hypoglycaemics

Guidelines (10)
Tables (1)

Table: Antidiabetic Agents, Use in Renal Impairment

Dosing of diabetes drugs in patients with renal impairment.

Oral and parenteral hypoglycaemics in the News

NICE approves new diabetes treatment for NHS prescribing

NICE approves new diabetes treatment for NHS prescribing

Ertugliflozin (Steglatro), the newest sodium glucose...

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

Cases of necrotising fasciitis of the genitalia or...

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Ertugliflozin (Steglatro) is a sodium glucose co-transporter...